Role of Non-coding RNA as a Biomarker of Response to Therapeutic Agents in Colorectal Cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Brieflands
Abstract
Chemoresistance is a severe drawback to the successful and effective treatment of colorectal cancer (CRC). Comprehensive molecular mechanisms of chemoresistance facilitate the development of effective therapeutic strategies to overcome chemoresistance in CRC. The dysregulation of several non-coding RNAs was related to chemoresistance in CRC.